As of 2025-05-17, the EV/EBITDA ratio of Oragenics Inc (OGEN) is -0.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OGEN's latest enterprise value is 3.76 mil USD. OGEN's TTM EBITDA according to its financial statements is -20.00 mil USD. Dividing these 2 quantities gives us the above OGEN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-03-14 | -0.27 |
| 2025-03-13 | -0.28 |
| 2025-03-12 | -0.28 |
| 2025-03-11 | -0.28 |
| 2025-03-10 | -0.28 |
| 2025-03-07 | -0.28 |
| 2025-03-06 | -0.27 |
| 2025-03-05 | -0.27 |
| 2025-03-04 | -0.26 |
| 2025-03-03 | -0.26 |
| 2025-02-28 | -0.28 |
| 2025-02-27 | -0.27 |
| 2025-02-26 | -0.27 |
| 2025-02-25 | -0.27 |
| 2025-02-24 | -0.27 |
| 2025-02-21 | -0.28 |
| 2025-02-20 | -0.28 |
| 2025-02-19 | -0.29 |
| 2025-02-18 | -0.28 |
| 2025-02-14 | -0.29 |
| 2025-02-13 | -0.29 |
| 2025-02-12 | -0.29 |
| 2025-02-11 | -0.26 |
| 2025-02-10 | -0.28 |
| 2025-02-07 | -0.25 |
| 2025-02-06 | -0.28 |
| 2025-02-05 | -0.29 |
| 2025-02-04 | -0.28 |
| 2025-02-03 | -0.29 |
| 2025-01-31 | -0.31 |
| 2025-01-30 | -0.30 |
| 2025-01-29 | -0.30 |
| 2025-01-28 | -0.30 |
| 2025-01-27 | -0.30 |
| 2025-01-24 | -0.30 |
| 2025-01-23 | -0.28 |
| 2025-01-22 | -0.28 |
| 2025-01-21 | -0.28 |
| 2025-01-17 | -0.28 |
| 2025-01-16 | -0.29 |
| 2025-01-15 | -0.30 |
| 2025-01-14 | -0.29 |
| 2025-01-13 | -0.32 |
| 2025-01-10 | -0.34 |
| 2025-01-08 | -0.33 |
| 2025-01-07 | -0.38 |
| 2025-01-06 | -0.41 |
| 2025-01-03 | -0.34 |
| 2025-01-02 | -0.36 |
| 2024-12-31 | -0.37 |